Literature DB >> 10360675

Overexpression of rck/p54, a DEAD box protein, in human colorectal tumours.

Y Nakagawa1, H Morikawa, I Hirata, M Shiozaki, A Matsumoto, K Maemura, T Nishikawa, M Niki, N Tanigawa, M Ikegami, K Katsu, Y Akao.   

Abstract

The RCK gene is a target of the t(11;14)(q23;q32) chromosomal translocation observed in human B-cell lymphoma, and the overexpression of its protein (rck/p54) by the translocation was shown to cause malignant transformation. The rck/p54 protein belongs to the DEAD box protein/RNA helicase family, which has a variety of functions such as translation initiation, pre-mRNA splicing and ribosome assembly. The expression of rck p54 in colorectal adenocarcinoma cells was examined by immunohistochemistry and Western blot analysis. The rck/p54 protein was found to be overexpressed in tumour tissues resected from 13 (50%) out of 26 cases of colorectal adenocarcinomas and two out of two (100%) cases of colonic severe dysplastic adenomas. In view of activities of rck/p54 determined in other tissue types, we suggest that rck/p54 may contribute to the cell proliferation and carcinogenesis at the translational level in the development of colorectal tumours.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10360675      PMCID: PMC2362290          DOI: 10.1038/sj.bjc.6690441

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  The RCK gene associated with t(11;14) translocation is distinct from the MLL/ALL-1 gene with t(4;11) and t(11;19) translocations.

Authors:  Y Akao; M Seto; K Yamamoto; S Iida; S Nakazawa; J Inazawa; T Abe; T Takahashi; R Ueda
Journal:  Cancer Res       Date:  1992-11-01       Impact factor: 12.701

2.  Bidirectional RNA helicase activity of eucaryotic translation initiation factors 4A and 4F.

Authors:  F Rozen; I Edery; K Meerovitch; T E Dever; W C Merrick; N Sonenberg
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

3.  Requirement of the DEAD-Box protein ded1p for messenger RNA translation.

Authors:  R Y Chuang; P L Weaver; Z Liu; T H Chang
Journal:  Science       Date:  1997-03-07       Impact factor: 47.728

4.  Xp54, the Xenopus homologue of human RNA helicase p54, is an integral component of stored mRNP particles in oocytes.

Authors:  M Ladomery; E Wade; J Sommerville
Journal:  Nucleic Acids Res       Date:  1997-03-01       Impact factor: 16.971

5.  Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap.

Authors:  A Lazaris-Karatzas; K S Montine; N Sonenberg
Journal:  Nature       Date:  1990-06-07       Impact factor: 49.962

6.  Protein determination in membrane and lipoprotein samples: manual and automated procedures.

Authors:  M A Markwell; S M Haas; N E Tolbert; L L Bieber
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

7.  Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo.

Authors:  C Grandori; J Mac; F Siëbelt; D E Ayer; R N Eisenman
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

Review 8.  Chromosomal translocations in human cancer.

Authors:  T H Rabbitts
Journal:  Nature       Date:  1994-11-10       Impact factor: 49.962

9.  The rck/p54 candidate proto-oncogene product is a 54-kilodalton D-E-A-D box protein differentially expressed in human and mouse tissues.

Authors:  Y Akao; O Marukawa; H Morikawa; K Nakao; M Kamei; T Hachiya; Y Tsujimoto
Journal:  Cancer Res       Date:  1995-08-01       Impact factor: 12.701

10.  Molecular cloning of the chromosomal breakpoint of a B-cell lymphoma with the t(11;14)(q23;q32) translocation.

Authors:  Y Akao; M Seto; T Takahashi; I Kubonishi; I Miyoshi; S Nakazawa; Y Tsujimoto; C M Croce; R Ueda
Journal:  Cancer Res       Date:  1991-03-01       Impact factor: 12.701

View more
  22 in total

1.  An essential role for the Saccharomyces cerevisiae DEAD-box helicase DHH1 in G1/S DNA-damage checkpoint recovery.

Authors:  Megan Bergkessel; Joseph C Reese
Journal:  Genetics       Date:  2004-05       Impact factor: 4.562

2.  General translational repression by activators of mRNA decapping.

Authors:  Jeff Coller; Roy Parker
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

3.  Crystal structure and functional analysis of DEAD-box protein Dhh1p.

Authors:  Zhihong Cheng; Jeff Coller; Roy Parker; Haiwei Song
Journal:  RNA       Date:  2005-06-29       Impact factor: 4.942

4.  Translation control: Learning from viruses, again.

Authors:  Juana Díez; Jennifer Jungfleisch
Journal:  RNA Biol       Date:  2017-05-10       Impact factor: 4.652

5.  A conserved role of a DEAD box helicase in mRNA masking.

Authors:  N Minshall; G Thom; N Standart
Journal:  RNA       Date:  2001-12       Impact factor: 4.942

Review 6.  The DEAD-box protein family of RNA helicases: sentinels for a myriad of cellular functions with emerging roles in tumorigenesis.

Authors:  Mohamed A M Ali
Journal:  Int J Clin Oncol       Date:  2021-03-03       Impact factor: 3.402

Review 7.  Nucleic acid sensing pattern recognition receptors in the development of colorectal cancer and colitis.

Authors:  Liangmei He; Yayun Chen; Yuanbing Wu; Ying Xu; Zixiang Zhang; Zhiping Liu
Journal:  Cell Mol Life Sci       Date:  2017-02-21       Impact factor: 9.261

8.  Cellular DEAD-box RNA helicase DDX6 modulates interaction of miR-122 with the 5' untranslated region of hepatitis C virus RNA.

Authors:  Jason M Biegel; Eric Henderson; Erica M Cox; Gaston Bonenfant; Rachel Netzband; Samantha Kahn; Rachel Eager; Cara T Pager
Journal:  Virology       Date:  2017-04-26       Impact factor: 3.616

9.  Downregulation of anti-oncomirs miR-143/145 cluster occurs before APC gene aberration in the development of colorectal tumors.

Authors:  Akemi Kamatani; Yoshihito Nakagawa; Yukihiro Akao; Naoko Maruyama; Mitsuo Nagasaka; Tomoyuki Shibata; Tomomitsu Tahara; Ichiro Hirata
Journal:  Med Mol Morphol       Date:  2013-02-09       Impact factor: 2.309

Review 10.  Cancer the'RBP'eutics-RNA-binding proteins as therapeutic targets for cancer.

Authors:  Shakur Mohibi; Xinbin Chen; Jin Zhang
Journal:  Pharmacol Ther       Date:  2019-07-11       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.